Navigating Drug Accessibility in Hematologic Malignancies

In this episode of The Hem Onc Pulse, host Dr. Rahul Banerjee sits down with Dr. Michelle Longmire, CEO and co-founder of Medable, to discuss one of the most pressing challenges in oncology today: drug accessibility. Despite the rapid pace of innovation in cancer therapeutics, many patients still face significant barriers to accessing life-saving treatments. Dr. Longmire offers insights into how decentralized clinical trials, digital platforms, and patient-centered design can help close the gap, particularly for underserved populations.

Together, Drs. Banerjee and Longmire explore systemic issues that contribute to limited drug access, from high costs and regulatory complexity to geographical and racial disparities in clinical trial participation. They also highlight promising models that are making oncology research more inclusive and accessible.